FindTrial
Sign In

A study to compare pain relieving effect of intrathecal morphine and adductor canal block in patients undergoing knee ligament repair surgery

Comparison of intrathecal morphine and adductor canal block for analgesic efficacy in patients undergoing knee arthroplasty-a randomized controlled study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071945
Enrollment
80
Registered
2024-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: M236- Other spontaneous disruption of ligament(s) of knee

Interventions

Intervention1: Intrathecal morphine: 100mcg of intrathecal morphine along with subarachnoid puncture Control Intervention1: Adductor canal block: with injection bupivacaine 0.25% over the medial aspec

Sponsors

Aiims Kalyani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients of Age 18-65 years of both sexes with American Society of Anesthesiologist (ASA) 1 and 2 undergoing knee arthroplasty under spinal anesthesia

Exclusion criteria

Exclusion criteria: total surgical duration more than 3 hours ASA 3 and 4 refuse to consent for spinal anesthesia history of coagulopathy with raised INR more than or equal to 1.5 local infection at needle insertion site history of psychiatric illness and on antipsychotic medications history of opioid dependence history of chronic pain

Design outcomes

Primary

MeasureTime frame
Cumulative morphine equivalent consumption Timepoint: 24 hours—

Secondary

MeasureTime frame
1.Numeric Rating scale for pain 2. Time to first postop mobilisation 3. Quadriceps muscle strength 4. Adverse effects (Nausea, Vomitting, pruritus) Timepoint: 1.Numeric Rating scale for pain at 0,2,4,6,8,12 & 24 hours 2. Time to first postop mobilisation 3. Quadriceps muscle strength at 6,8,12 & 24 hours 4. Adverse effects (Nausea, Vomitting, pruritus)—

Countries

India

Contacts

Public ContactDr.Anjum Naz

Aiims,Kalyani

sekar.anesth@aiimskalyani.edu.in8146555023

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026